Health technology trade association ABHI has announced that specialist marketing, PR and communications agency Highland Marketing has joined its membership.
Highland Marketing has worked with technology providers throughout the health and care sector for more than two decades, helping to bring innovations to market and raise awareness of the positive impact technologies enable for clinical teams and patients.
Frimley Health NHS Foundation Trust and Qure.ai have announced the early results of a pilot study using an innovative radiology AI solution to read and differentiate between normal and abnormal chest X-rays (CXRs).
qXR, a CE class IIb MDR cleared solution developed by Qure, was deployed with the hypothesis to categorise normal x-rays - approximately 40% of the caseload from GP and outpatient requests - and augment overall reporting efficiency.
The Department of Health and Social Care has just published a strategy for medical technology. The Highland Marketing advisory board asked what chief information officers need to know about it; and how they can make the most of the opportunities that will come from integrating device data with medical records. 
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced that the Philips-coordinated IMAGIO consortium [1] of clinical partners has been awarded a EUR 24 million Innovative Health Initiative (IHI) grant, complemented with additional resources and funding from industry partners [2], to carry out research into less invasive cancer treatments. 
NHS Fife is working with Buddy Healthcare on a digital pre-op pathway, so orthopaedic patients can complete assessments on an app and clinicians can use the data to make the best possible use of outpatient clinic and theatre time.
The Scottish health board has adopted the digital platform, which it calls ELSIE (the Electronic Pre-Operative Assessment App).
A new microperspective in the ACS journal Medicinal Chemistry Letters evaluates recent research on artificial intelligence (AI)-generated molecular structures from the point of view of the medicinal chemist and recommends guidelines for assessing the novelty and validity of these compounds. 
Siemens Healthineers has opened its new Innovation Center in Erlangen, Germany, in the heart of the regional medical technology research area known as Medical Valley. The focus is on open innovation by collaborating with external partner companies, start-ups and academic and clinical institutions to improve healthcare worldwide.